PET Radiochemistry Indian Medical PG Practice Questions and MCQs
Practice Indian Medical PG questions for PET Radiochemistry. These multiple choice questions (MCQs) cover important concepts and help you prepare for your exams.
PET Radiochemistry Indian Medical PG Question 1: A pregnant woman with head trauma requires a CT scan of the head. What is the most effective radiation protection measure for the fetus?
- A. Using MRI instead
- B. Lead apron over abdomen
- C. Avoid CT, rely on clinical assessment
- D. Reduced mA and kVp (Correct Answer)
PET Radiochemistry Explanation: ***Reduced mA and kVp***
- **Optimizing scan parameters** (reducing mA and kVp) is the most effective way to minimize radiation dose during head CT in pregnancy.
- Modern CT scanners with **iterative reconstruction** allow significant dose reduction without compromising diagnostic image quality.
- The fetal dose from head CT is already negligible (< 0.01 mGy), but dose optimization further reduces any potential risk.
- This directly addresses the radiation source rather than attempting to shield scatter radiation.
*Lead apron over abdomen*
- Lead shielding provides **minimal to no benefit** during head CT as the fetus is far from the primary beam.
- Scatter radiation reaching the pelvis from head CT is negligible.
- Lead aprons can interfere with **automatic exposure control (AEC)**, potentially increasing rather than decreasing dose.
- Modern radiology guidelines (ACR, ICRP) no longer routinely recommend gonadal shielding for most CT examinations.
*CT not recommended*
- Withholding indicated imaging in trauma is **inappropriate and potentially dangerous**.
- The diagnostic benefit of head CT in trauma far outweighs the negligible fetal risk.
- **Maternal well-being** is the priority, and missing a critical head injury poses greater risk to both mother and fetus.
*Using MRI instead*
- While MRI has no ionizing radiation, it is **not appropriate for acute trauma** evaluation.
- MRI takes longer to perform, requires patient cooperation, and is less readily available in emergency settings.
- CT remains the **gold standard** for acute head trauma assessment.
PET Radiochemistry Indian Medical PG Question 2: Which of the following is the platinum-based chemotherapeutic agent used as first-line treatment for ovarian carcinoma?
- A. Cyclophosphamide
- B. Methotrexate
- C. Cisplatin (Correct Answer)
- D. Dacarbazine
PET Radiochemistry Explanation: ***Cisplatin***
- **Cisplatin** is a platinum-based chemotherapy drug that forms **DNA cross-links**, inhibiting DNA synthesis and leading to the death of rapidly dividing cells, making it highly effective against **ovarian carcinoma**.
- It is a cornerstone of chemotherapy regimens for ovarian cancer, often used in combination with other agents such as paclitaxel.
*Methotrexate*
- **Methotrexate** is an **antimetabolite** that inhibits dihydrofolate reductase, thereby interfering with DNA synthesis.
- While it is used in various cancers like leukemia, lymphoma, and some solid tumors (e.g., breast cancer, gestational trophoblastic disease), it is **not a primary recommended drug for ovarian carcinoma**.
*Cyclophosphamide*
- **Cyclophosphamide** is an **alkylating agent** that causes DNA damage, leading to cell death.
- It is used in many cancers, including lymphoma, breast cancer, and some leukemias, but it is **not a first-line or primary agent for ovarian carcinoma** in contemporary treatment guidelines.
*Dacarbazine*
- **Dacarbazine** is an **alkylating agent** primarily used in the treatment of **malignant melanoma** and Hodgkin lymphoma.
- It is **not indicated for the treatment of ovarian carcinoma**.
PET Radiochemistry Indian Medical PG Question 3: A lady presented with a 4 cm tumor in the left parietal lobe for which she underwent surgery and radiotherapy. After 3 months she presented with headache and vomiting. Which of the following would characterize the lesion in the patient?
- A. Digital subtraction angiography with dual source CT scan
- B. Gd-enhanced MRI
- C. 99Tc-HMPAO SPECT brain
- D. 18FDG PET Scan (Correct Answer)
PET Radiochemistry Explanation: ***18FDG PET Scan***
- This patient, presenting with new neurological symptoms after **surgery and radiotherapy** for a cerebral tumor, faces a diagnostic dilemma: differentiating between **tumor recurrence** and **radiation necrosis**.
- **18FDG PET scans** effectively distinguish between these two conditions because viable tumor cells exhibit high metabolic activity and thus actively take up **fluorodeoxyglucose (FDG)**, while radiation necrosis is metabolically inactive and shows little to no FDG uptake.
*Digital subtraction angiography with dual source CT scan*
- **Digital subtraction angiography (DSA)** is primarily used to visualize **vascular structures** and is not the modality of choice for differentiating tumor recurrence from radiation necrosis.
- A **dual-source CT scan** is useful for rapid imaging and dynamic studies but lacks the metabolic information needed for this specific differentiation.
*Gd-enhanced MRI*
- While **Gd-enhanced MRI** is excellent for detecting **structural changes** and **blood-brain barrier disruption**, it often cannot definitively differentiate between **tumor recurrence** and **radiation necrosis**.
- Both conditions can present with similar **enhancement patterns** on MRI, making differentiation challenging without additional metabolic information.
*99Tc-HMPAO SPECT brain*
- **99mTc-HMPAO SPECT** measures **regional cerebral blood flow (rCBF)**, which can be altered in both tumors and areas of radiation injury.
- However, it does not provide the specific metabolic information (glucose metabolism) needed to reliably distinguish between **viable tumor cells** and **radiation necrosis** as effectively as FDG PET.
PET Radiochemistry Indian Medical PG Question 4: The substance most commonly used for protection against X-ray radiation is?
- A. Zinc
- B. Steel
- C. Lead (Correct Answer)
- D. Porcelain
PET Radiochemistry Explanation: ***Lead***
- **Lead** is highly effective at attenuating X-rays due to its **high atomic number** and **high density**.
- Its density allows it to absorb a significant amount of **radiative energy** in a relatively thin layer, making it ideal for shielding.
*Zinc*
- While zinc can absorb some radiation, its **lower atomic number** and **density** make it significantly less effective than lead for X-ray shielding.
- It would require a much greater thickness of zinc to achieve the same protective effect as lead.
*Steel*
- Steel has a higher density than many common materials, but it is **less dense** and has a **lower atomic number** than lead.
- Therefore, steel provides less effective shielding against X-rays compared to lead, requiring thicker barriers.
*Porcelain*
- Porcelain is a type of ceramic material with a **low atomic number** and **low density**, making it a poor choice for X-ray protection.
- It would allow most X-ray radiation to pass through, offering minimal shielding.
PET Radiochemistry Indian Medical PG Question 5: The most appropriate first-line imaging modality to detect adrenal metastasis due to bronchogenic carcinoma is:
- A. PET scan
- B. MRI of the abdomen
- C. Adrenal radionuclide scan
- D. Contrast Enhanced CT abdomen (Correct Answer)
PET Radiochemistry Explanation: **Contrast Enhanced CT abdomen**
- **Contrast-enhanced CT abdomen** is generally considered the most sensitive and cost-effective imaging modality for detecting **adrenal metastases**.
- It allows for detailed visualization of adrenal gland morphology, including size, shape, and enhancement patterns, which can help differentiate benign from malignant lesions.
*PET scan*
- While **PET (Positron Emission Tomography) scans** are highly sensitive for detecting metabolically active metastatic disease, they are often used as a secondary imaging modality to characterize indeterminate lesions found on CT or MRI.
- **PET scans** can have false positives in benign adrenal tumors (e.g., adenomas rich in fat) and are less readily available or higher in cost for initial screening compared to CT.
*MRI of the abdomen*
- **MRI of the abdomen** can be very useful for further characterization of adrenal masses, especially for distinguishing between lipid-rich adenomas and metastases.
- However, for initial detection, especially in the context of screening for distant metastases from bronchogenic carcinoma, **CT is generally preferred due to its wider availability, speed, and lower cost**.
*Adrenal radionuclide scan*
- **Adrenal radionuclide scans** (e.g., using MIBG or iodocholesterol) are primarily used for functional imaging of adrenal glands, typically to detect specific types of tumors like pheochromocytomas or aldosteronomas.
- These scans are **not sensitive for detecting adrenal metastases** from bronchogenic carcinoma, as the metastatic lesions do not typically exhibit the specific uptake patterns targeted by these radiotracers.
PET Radiochemistry Indian Medical PG Question 6: A research team is developing a new radiotracer for imaging hypoxia in tumors. They need to select between 18F-labeled and 64Cu-labeled versions of the same molecule. Considering half-lives (18F: 110 min, 64Cu: 12.7 hours), positron ranges, and clinical applicability, which choice and rationale is most appropriate?
- A. 64Cu for longer imaging window despite inferior image quality
- B. 64Cu because shorter positron range improves resolution
- C. 18F for better spatial resolution despite requiring on-site cyclotron (Correct Answer)
- D. 18F because longer half-life allows delayed imaging
PET Radiochemistry Explanation: ***18F for better spatial resolution despite requiring on-site cyclotron***
- **18F** has a shorter **positron range** compared to **64Cu**, which minimizes the distance the positron travels before annihilation, leading to superior **spatial resolution**.
- While it necessitates proximity to a **cyclotron** due to a 110-minute half-life, this timeframe is sufficient for most **hypoxia imaging** tracers to reach a high **target-to-background ratio**.
*64Cu for longer imaging window despite inferior image quality*
- **64Cu** provides a longer imaging window due to its **12.7-hour half-life**, but its longer **positron range** leads to increased **blurring** and poorer resolution.
- For diagnostic **tumor hypoxia**, the extra-long window is often unnecessary and leads to a higher **absorbed radiation dose** for the patient.
*64Cu because shorter positron range improves resolution*
- This statement is factually incorrect as **64Cu** actually has a significantly longer **effective positron range** than **18F**.
- Higher **energy positrons** travel further in tissue, which degrades the **image quality** by misplacing the site of annihilation relative to the source.
*18F because longer half-life allows delayed imaging*
- This is incorrect as **18F** has a much shorter half-life (**110 minutes**) compared to the **12.7 hours** of **64Cu**.
- The shorter half-life of **18F** prevents very late delayed imaging but helps in keeping the total **patient radiation exposure** lower.
PET Radiochemistry Indian Medical PG Question 7: In designing a clinical protocol for PSMA PET imaging in prostate cancer, which combination of factors would provide optimal image quality while minimizing radiation exposure?
- A. 18F-PSMA with 4 hour delayed imaging
- B. 68Ga-PSMA with 3 hour uptake time without furosemide
- C. 68Ga-PSMA with 1 hour uptake time and furosemide administration (Correct Answer)
- D. 18F-PSMA with 30 minutes uptake time and forced hydration
PET Radiochemistry Explanation: ***68Ga-PSMA with 1 hour uptake time and furosemide administration***
- An **uptake time of 60 minutes** is the standard for **68Ga-PSMA**, providing an optimal **target-to-background ratio** (TBR) while maintaining efficient clinical workflow.
- The administration of **furosemide** (a loop diuretic) promotes **urinary washout** of the tracer, reducing interfering **bladder activity** and lowering the radiation dose to the urinary tract.
*18F-PSMA with 4 hour delayed imaging*
- While **18F-labeled tracers** have a longer half-life, a 4-hour delay is excessive and leads to significant **decay of activity**, potentially requiring higher initial doses and increasing **radiation exposure**.
- Such long delays are not practical for routine clinical protocols and do not provide a significant clinical advantage over standard 1-2 hour imaging for most **PSMA** ligands.
*68Ga-PSMA with 3 hour uptake time without furosemide*
- **68Ga** has a short physical half-life (68 minutes), so a 3-hour wait significantly reduces the **count rate**, leading to poor **image quality** due to increased noise.
- Omitting **furosemide** results in high tracer concentration in the **bladder**, which can obscure local recurrence in the **prostate bed** or nearby pelvic lymph nodes via **halo artifacts**.
*18F-PSMA with 30 minutes uptake time and forced hydration*
- A **30-minute uptake time** is generally insufficient for optimal **tracer internalization** into prostate cancer cells, resulting in a lower **tumor-to-background ratio**.
- Although **forced hydration** helps, it is less effective than **furosemide** at rapidly clearing the high-intensity tracer from the **distal ureters** and bladder during the peak imaging window.
PET Radiochemistry Indian Medical PG Question 8: A patient with treated breast cancer shows a liver lesion on CT. FDG-PET shows SUVmax of 2.8 in the lesion. Follow-up scan after 3 months shows increase in size but SUVmax decreased to 1.9. What is the most likely explanation?
- A. Progressive disease requiring treatment escalation
- B. Treatment-induced necrosis with favorable prognosis (Correct Answer)
- C. Flare phenomenon indicating treatment response
- D. Infection complicating the metastasis
PET Radiochemistry Explanation: ***Treatment-induced necrosis with favorable prognosis***
- A decrease in **SUVmax** indicates a reduction in **metabolic activity** and viable tumor cells, even if the physical dimensions of the lesion increase.
- The increase in size is often due to **necrosis, edema, or inflammation** following successful therapy, representing a favorable response to treatment rather than failure.
*Progressive disease requiring treatment escalation*
- Progressive disease typically presents with an **increase in both size and SUVmax**, reflecting active metabolic growth of the tumor.
- Relying solely on **CT size measurements** (like RECIST criteria) can be misleading when PET shows a significant drop in **glucose metabolism**.
*Flare phenomenon indicating treatment response*
- The **flare phenomenon** usually refers to a transient *increase* in tracer uptake (SUVmax) shortly after starting treatment (e.g., bone flare in breast cancer patients).
- In this scenario, the activity **decreased over 3 months**, which is more consistent with a sustained metabolic response than a metabolic flare.
*Infection complicating the metastasis*
- An active infection or inflammatory process would typically lead to an **increase in SUVmax** due to high metabolic activity in activated white blood cells.
- There is no clinical information provided to suggest systemic **fever or local infection**, and the metabolic trend (decreasing SUV) contradicts an inflammatory spike.
PET Radiochemistry Indian Medical PG Question 9: A 58-year-old woman with gastrinoma undergoes both FDG-PET and 68Ga-DOTATATE PET scans. FDG-PET shows minimal uptake (SUVmax 2.1) while DOTATATE scan shows intense uptake (SUVmax 45). What does this pattern indicate about tumor biology?
- A. High grade aggressive tumor
- B. Well-differentiated slow-growing tumor (Correct Answer)
- C. Necrotic tumor with inflammation
- D. False positive DOTATATE scan
PET Radiochemistry Explanation: ***Well-differentiated slow-growing tumor***
- High **DOTATATE uptake** indicates dense expression of **somatostatin receptors (SSTRs)**, which is a hallmark of well-differentiated neuroendocrine tumors.
- Low **FDG uptake** (low SUVmax) reflects a low rate of glucose metabolism, signifying a **low-grade (G1/G2)** tumor with a slow proliferation rate.
*High grade aggressive tumor*
- Aggressive, high-grade neuroendocrine carcinomas (G3) typically show high **FDG avidity** because they rely heavily on glycolysis for energy.
- These tumors often lose their **somatostatin receptor expression**, leading to low or absent uptake on a **DOTATATE scan**.
*Necrotic tumor with inflammation*
- **Necrosis** generally presents as a photopenic (cold) area in the center of a lesion on PET imaging, not intense DOTATATE uptake.
- **Inflammation** would typically result in increased **FDG uptake** due to high metabolic activity in activated leukocytes, rather than isolated high DOTATATE avidity.
*False positive DOTATATE scan*
- Intense uptake with an **SUVmax of 45** is highly specific for SSTR-rich tissues and is considered diagnostic for neuroendocrine pathology in this clinical context.
- A **gastrinoma** is a known neuroendocrine tumor (NET) that consistently expresses these receptors, making a false positive highly unlikely.
PET Radiochemistry Indian Medical PG Question 10: A 45-year-old diabetic patient presents for FDG-PET scan for lymphoma staging. Blood glucose is 220 mg/dL. What is the most appropriate management before proceeding with imaging?
- A. Administer insulin and delay scan until glucose <150 mg/dL (Correct Answer)
- B. Double the FDG dose to compensate
- C. Cancel scan and reschedule after glucose control
- D. Proceed immediately with scanning
PET Radiochemistry Explanation: ***Administer insulin and delay scan until glucose <150 mg/dL***
- **Hyperglycemia** causes competitive inhibition of **FDG uptake** in tumor cells, as glucose and FDG compete for the same **GLUT transporters**.
- Administering insulin lowers blood glucose to an acceptable range (ideally **<150 mg/dL**) to ensure optimal **diagnostic accuracy** and image quality, though scanning should occur at least 2 hours after insulin administration to avoid muscle uptake.
*Double the FDG dose to compensate*
- Increasing the **FDG dose** does not bypass the competitive inhibition caused by serum glucose and will only increase **radiation exposure** unnecessarily.
- High blood sugar levels will still prioritize **native glucose** over FDG into cells, resulting in a poor **signal-to-noise ratio**.
*Cancel scan and reschedule after glucose control*
- While long-term control is ideal, acute management with **short-acting insulin** allows the scan to proceed on the same day once levels fall below the threshold.
- Rescheduling is only necessary if the patient's **blood glucose** remains persistently high and unresponsive to immediate clinical intervention.
*Proceed immediately with scanning*
- Scanning with a glucose level of **220 mg/dL** leads to poor image quality and potential **false-negative** results due to diminished tracer uptake in the lymphoma.
- Elevated **endogenous glucose** saturates the receptors, preventing the radioactive tracer from adequately labeling the **metabolically active** tumor sites.
More PET Radiochemistry Indian Medical PG questions available in the OnCourse app. Practice MCQs, flashcards, and get detailed explanations.
